One of the main growth-driving factors for global hypodermic needles is the growing geriatric population and demand for vaccines. The rising prevalence of various chronic diseases, as well as the growing number of hospitals and clinics in developing countries, are expected to boost the market's growth over the forecast period. Increasing cases of chronic diseases such as cancer, cardiovascular disorders and others worldwide prove to be the primary growth driving factor.
Prevalence of chronic diseases can be due to sedentary lifestyles, obesity, poor eating patterns, and high tobacco and alcohol intake. According to the American Heart Association's 2019 study, cardiovascular disease (CVD) is the leading global cause of death, with more than 17.6 million deaths a year in 2016, and more than 23.6 million by 2030. Diabetes is predicted to become more prevalent in the future. Injection and infusion procedures are being used more often as a result of successful government programmes.
read more..